Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
6.99Price to Book
VS
Market
Sector
Industry
History
$ 3.15Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information
Ticker
VVOSCompany Name
VIVOS THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQVIVOS THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VVOS - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 4.58M | $ 32.05M | 6.99 |
| 3/31/2025 | $ 4.41M | $ 18.02M | 4.09 |
| 12/31/2024 | $ 7.95M | $ 16.79M | 2.11 |
| 9/30/2024 | $ 7.67M | $ 15.09M | 1.97 |
| 6/30/2024 | $ 6.35M | $ 8.06M | 1.27 |
| 3/31/2024 | $ 582K | $ 8.04M | 13.81 |
| 12/31/2023 | $ 411K | $ 13.19M | 32.1 |
| 9/30/2023 | $ 46K | $ 4.47M | 97.08 |
| 6/30/2023 | $ 2.11M | $ 10.27M | 4.88 |
| 3/31/2023 | $ 6.99M | $ 14.07M | 2.01 |
Key Performance Insights, Last 5 Years
- VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, VIVOS THERAPEUTICS INC's average P/B has been 10.85.
- The median P/B for VIVOS THERAPEUTICS INC during this period was 2.65
- VIVOS THERAPEUTICS INC reached its highest P/B over the past 5 years at 97.08.
- The lowest P/B recorded by VIVOS THERAPEUTICS INC in the same timeframe 1.24
VIVOS THERAPEUTICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for VIVOS THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Equity [ $ -2.94M ]
(=) P/B [ 0 ] VVOS - Price to Book, Last 5 years
1.24
Minimum
Sep 30, 2022
97.08
Maximum
Sep 30, 2023
10.85
Average
2.65
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |